CEO
Roger C Hahn
Roger is a registered patent attorney who patented one of the first Single Nucleotide Polymorphism (SNP) patents before the U.S. Patent Office. He has written numerous papers on the intersection of personalized medicine innovation and patent law. Roger is a biomedical engineer by training and holds a Master Degree in Biomedical Engineering from The Johns Hopkins University where he studied bioinformatics.